Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study
Hyun Ji Lyou(St. Mary's Hospital), Eun Bin Cho(Changwon National University), Ha Young Shin(Yonsei University), Seol‐Hee Baek(Korea University Medical Center), Jin Myoung Seok(Samsung Medical Center), Byung‐Jo Kim(Korea University), Seong‐il Oh(Kyung Hee University), Jeeyoung Oh(Université Paris-Sud), Young Nam Kwon(Yonsei University), Sun‐Young Kim(Hanyang Cyber University), Seung Woo Kim(Ulsan College), Hye Lim Lee(Korea University Medical Center), Byoung Joon Kim(Samsung Medical Center), Ju‐Hong Min(Samsung (South Korea))
Cited by 1
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82